ENTO

Entero Therapeutics
ENTO

Overview Fund Trends Analyst Outlook Journalist POV

4 hedge funds and large institutions have $3.72M invested in Entero Therapeutics in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

Holders
4
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$508K
2
+$410K
3
+$328K

Top Sellers

1
-$161K
2
-$141K
3
-$69K
4
BlackRock
BlackRock
New York
-$57K
5
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
-$57K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.01M
2
$907K
3
$819K
4
$328K
5
$249K
6
$131K
7
$89K
8
$57K
9
$53K
10
$43K
11
$12K
12
$12K
13
$6K
14
–